salary pursuant to the Restated Malone Agreement was $400,000 per year. Mr. Malone’s annual base salary was increased to $480,000 per year effective June 10, 2025 upon his appointment as our President and Chief Executive Officer. The Restated Malone Agreement also provides for us to make certain payments to Mr. Malone in the event we terminate his employment without cause or upon the occurrence of certain events relating to a change in control of the Company, as described under “Involuntary Termination” and “Termination Following a Change in Control” under the heading “Potential Payments Upon Termination or Change in Control.”
Pursuant to the Restated Malone Agreement, if Mr. Malone’s employment with us is terminated for any reason, he will be subject to a covenant not to disclose to anyone our confidential information as well as a 12-month covenant not to compete with us and not to interfere in certain of our business relationships.
The Restated Malone Agreement also provides that we will indemnify Mr. Malone for all acts or omissions and for any suits brought against him which relate to duties he performed in good faith for us.
Daniel J. Thoren. We entered into an Amended and Restated Employment Agreement (the “Restated Thoren Agreement”) with Mr. Thoren effective as of February 5, 2025, which amended and restated the prior employment agreement between us and Mr. Thoren dated as of August 31, 2021. The Restated Thoren Agreement was in effect for all of fiscal year 2026 and governed Mr. Thoren’s employment for the year. Pursuant to the terms of the Restated Thoren Agreement, Mr. Thoren served as Chief Executive Officer of the Company through the close of business on June 9, 2025 after which Mr. Thoren transitioned to Executive Chairman effective as of June 10, 2025. The Restated Thoren Agreement had a term of one-year and automatically renewed such that it always had a one-year term remaining, unless we or Mr. Thoren elect not to extend the term further, in which case the term would end on the first anniversary of the date on which notice of such election not to extend is given. Effective June 10, 2025, Mr. Thoren’s base salary as Executive Chairman was equal to a rate of $250,000 per annum and he was required to devote approximately thirty (30) hours per week to his position. The Restated Thoren Agreement also provided for us to make certain payments to Mr. Thoren in the event we terminate his employment without cause or upon the occurrence of certain events relating to a change in control of the Company, as described under “Involuntary Termination” and “Termination Following a Change in Control” under the heading “Potential Payments Upon Termination or Change in Control.”
Under the Restated Thoren Agreement, if Mr. Thoren’s employment with us was terminated for any reason, he would be subject to a covenant not to disclose to anyone our confidential information as well as a 12-month covenant not to compete with us and not to interfere in certain of our business relationships. The Restated Thoren Agreement also provided that we would indemnify Mr. Thoren for all acts or omissions and for any suits brought against him which relate to duties he performed in good faith for us.
We entered into a Transition and Retirement Agreement (the “Thoren T&R Agreement”) with Mr. Thoren effective as of June 15, 2026, that replaced the Restated Thoren Agreement (as defined below) which was terminated on June 15, 2026. Pursuant to the terms of the Thoren T&R Agreement, Mr. Thoren transitioned into the role of Strategic Advisor on an at-will basis until June 15, 2027, unless terminated sooner by us or Mr. Thoren, (the “Transition Period”). During the Transition Period, Mr. Thoren will receive an annual base salary of $150,000 and will continue to be eligible to participate in such other benefits (including health insurance) of the Company that may be in effect from time to time and as may be available to other similarly situated employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plans and arrangements. Mr. Thoren’s outstanding unvested PSUs and RSUs will continue to vest during the Transition Period, subject to all applicable terms of any such awards. If, prior to June 15, 2027, Mr. Thoren (a) is terminated for reasons other than death, disability or cause, or (b) resigns because of a material breach of the Thoren T&R Agreement by us that remains materially uncured after 30 days’ prior written notice, then his outstanding, unvested RSUs will remain outstanding and continue to vest until June 16, 2027 and his outstanding, unvested PSUs will remain outstanding until the performance conditions have been determined and will vest as if he had been employed until June 16, 2027 in accordance with the terms and conditions of the Thoren T&R Agreement. During the Transition Period, Mr. Thoren is required to devote approximately thirty (30) hours per week to his position.
Under the Thoren T&R Agreement, if Mr. Thoren’s employment with us is terminated for any reason, he will be subject to a covenant not to disclose to anyone our confidential information as well as a 12-month covenant not to compete with us and not to interfere in certain of our business relationships.
The Thoren T&R Agreement also provides that we will indemnify Mr. Thoren for all acts or omissions and for any suits brought against him which relate to duties he performed in good faith for us.
Christopher J. Thome. As of March 7, 2022, we entered into an Employment Agreement, effective as of April 4, 2022 with Mr. Thome, our Vice President – Finance, Chief Financial Officer, Chief Accounting Officer and Corporate Secretary. Mr. Thome’s agreement automatically renews such that it always has a one-year term remaining, unless we or Mr. Thome elect not to extend the term further, in which case the term will end on the first anniversary of the date on which notice of such election not to extend is given. If not terminated sooner, the agreement will end on the last day of the month in which Mr. Thome turns 65. Mr. Thome’s initial base salary rate pursuant to the agreement was $290,000 per year. The agreement also provides for us to make certain payments to Mr. Thome in the event we terminate his employment without cause or upon the occurrence of certain events relating to a change in control of the Company, as described under “Involuntary Termination” and “Termination Following a Change in Control” under the heading “Potential Payments Upon Termination or Change in Control.”
In addition, if Mr. Thome’s employment with us is terminated for any reason, he will be subject to a covenant not to disclose to anyone our confidential information as well as a 12-month covenant not to compete with us and not to interfere in certain of our business relationships.
The agreement also provides that we will indemnify Mr. Thome for all acts or omissions and for any suits brought against him which relate to duties he performed in good faith for us.